People · Operator

Michel P. Trudeau

Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals

1
Companies
1
Filings
$787K
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Valeo Pharma Inc.PharmaceuticalsPre-Seed$787K$16.0M2021
Operator network

Michel P. Trudeau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Frederic J. Fasano · 1 companies · 1 sharedFrederic J. FasanoGuy-Paul Allard · 1 companies · 1 sharedGuy-Paul AllardHelen P. Saviuk · 1 companies · 1 sharedHelen P. SaviukJeff P. Skinner · 1 companies · 1 sharedJeff P. SkinnerLuc P. Mainville · 1 companies · 1 sharedLuc P. MainvilleMaureen C. Breenan · 1 companies · 1 sharedMaureen C. BreenanMichael G. Wells · 1 companies · 1 sharedMichael G. WellsMichelle P. Brien · 1 companies · 1 sharedMichelle P. BrienNathalie P. Therrien · 1 companies · 1 sharedNathalie P. Therr…Nelly P. Komari · 1 companies · 1 sharedNelly P. KomariRichard J. Mackay · 1 companies · 1 sharedRichard J. MackaySteve J. Saviuk · 1 companies · 1 sharedSteve J. SaviukVincent P. Hogue · 1 companies · 1 sharedVincent P. HogueValeo Pharma Inc. · $0.8M raisedValeo Pharma Inc.Michel P. TrudeauMT
Michel P. Trudeau Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Michel P. Trudeau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jeff P. Skinner11
Vincent P. Hogue11
Frederic J. Fasano11
Steve J. Saviuk11
Michael G. Wells11
Richard J. Mackay11
Guy-Paul Allard11
Luc P. Mainville11
Helen P. Saviuk11
Michelle P. Brien11
Nathalie P. Therrien11
Nelly P. Komari11
Maureen C. Breenan11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.